PD-Rx Pharmaceuticals, Inc. 2022-07-06 Health serious FDA
Health · FDA · Recall #FDA-D-1162-2022
Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged… Recall
Issued July 6, 2022 · PD-Rx Pharmaceuticals, Inc.
In July 2022, PD-Rx Pharmaceuticals, Inc. recalled the Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
What you should do
- 1 Stop using Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact PD-Rx Pharmaceuticals, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- PD-Rx Pharmaceuticals, Inc.
- Category
- Health
- Recall date
- July 6, 2022
- Units affected
- Not reported
- Sold at
- Nationwide
- Recall number
- FDA-D-1162-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- PD-Rx Pharmaceuticals, Inc. has 5 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.